MedMira Increases Sales Capacity in Canada, Adding VWR as Distributor

About this update from Medmira Inc.

[{"type":"text","content":"\n\n\n\nHALIFAX, July 21 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and\nsolutions, announced today that VWR International, LLC (VWR) has joined the\nCompany's Canadian distribution network. Headquartered in West Chester,\nPennsylvania, VWR is a global laboratory supply and distribution company with\nworldwide sales in excess of $3.7 billion.\n\n\n"Canada is an important market for MedMira and increasing our sales\ncapacity with new distribution channels is key to maintaining and expanding\nour market position. Adding VWR to our Canadian distribution network will\nboost our sales revenues and enable us to develop and capitalize on\nopportunities to launch new products in Canada," said Hermes Chan, CEO,\nMedMira.\n\n\n"We provide our customers with the most innovative products available on\nthe market today. Adding MedMira's 3-minute rapid HIV test to our product\nportfolio will provide our Canadian customers with a critical diagnostic\ntool," said Mark McLoughlin, Senior Vice President, Category Management North\nAmerica, VWR.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals with reliable, rapid diagnosis for diseases such as HIV and\nhepatitis C in just three minutes. The company's tests are sold under the\nReveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global\nmarkets. MedMira's rapid HIV test is the only one in the world to achieve\nregulatory approvals in Canada, the United States, China and the European\nUnion. MedMira's corporate offices and manufacturing facilities are located in\nHalifax, Nova Scotia, Canada. For more information visit MedMira's website at\nwww.medmira.com.\n\n\nThis news release contains forward-looking statements, which involve risk\nand uncertainties and reflect the company's current expectation regarding\nfuture events. Actual events could materially differ from those projected\nherein and depend on a number of factors including, but not limited to,\nchanging market conditions, successful and timely completion of clinical\nstudies, uncertainties related to the regulatory approval process,\nestablishment of corporate alliances and other risks deta...

More updates from Medmira Inc.